Women's perspectives on human papillomavirus self-sampling in the context of the UK cervical screening programme

被引:22
|
作者
Williams, Denitza [1 ]
Davies, Myfanwy [2 ]
Fiander, Alison [3 ]
Farewell, Daniel [1 ]
Hillier, Sharon [4 ]
Brain, Kate [1 ]
机构
[1] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales
[2] Bangor Univ, Sch Social Sci, Bangor, Gwynedd, Wales
[3] Royal Coll Obstetricians & Gynaecologists, Leading Safe Choices Programme, London, England
[4] Publ Hlth Wales, Screening Div, Cardiff, S Glam, Wales
基金
英国医学研究理事会;
关键词
attitudes; cervical screening; HPV; human papillomavirus; intentions; self-sampling; CANCER; HPV; ACCEPTABILITY; ENGLAND; COHORT; TRIAL;
D O I
10.1111/hex.12544
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundTesting for human papillomavirus (HPV) is being incorporated into the cervical screening programme, with the probable future introduction of HPV as a primary test and a possibility of HPV self-sampling. In anticipation of this development, we sought to inform future policy and practice by identifying potential barriers to HPV self-sampling. MethodsA cross-sectional survey of 194 women aged 20-64years was conducted. Logistic regression analysis was used to identify determinants of self-sampling intentions. A purposive subsample of 19 women who reported low self-sampling intentions were interviewed. Interviews were framework-analysed. ResultsMost survey participants (N=133, 69.3%) intended to HPV self-sample. Lower intention was associated with lower self-efficacy (OR=24.96, P.001), lower education (OR=6.06, P.05) and lower perceived importance of HPV as a cause of cervical cancer (OR=2.33, P.05). Interviews revealed personal and system-related barriers. Personal barriers included a lack of knowledge about HPV self-sampling, women's low confidence in their ability to self-sample correctly and low confidence in the subsequent results. System-related factors included a lack of confidence in the rationale for modifying the current cervical screening programme, and concerns about sample contamination and identity theft. ConclusionsInsights gained from this research can be used to guide further enquiry into the possibility of HPV self-sampling and to help inform future policy and practice. Personal and system-related barriers including low confidence in the reasons for changing current cervical screening provision need to be addressed, should HPV self-sampling be incorporated into the cervical screening programme.
引用
收藏
页码:1031 / 1040
页数:10
相关论文
共 50 条
  • [41] Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology
    Belinson, JL
    Qiao, YL
    Pretorius, RG
    Zhang, WH
    Rong, SD
    Huang, MN
    Zhao, FH
    Wu, LY
    Ren, SD
    Huang, RD
    Washington, MF
    Pan, QJ
    Li, L
    Fife, D
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (06) : 819 - 826
  • [42] Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
    Laura Reques
    Camille Rolland
    Anne Lallemand
    Najat Lahmidi
    Ezequiel Aranda-Fernández
    Antonio Lazzarino
    Julie Bottero
    Françoise Hamers
    Christine Bergeron
    Ken Haguenoer
    Guy Launoy
    Niklas Luhmann
    BMC Women's Health, 21
  • [43] Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
    Reques, Laura
    Rolland, Camille
    Lallemand, Anne
    Lahmidi, Najat
    Aranda-Fernandez, Ezequiel
    Lazzarino, Antonio
    Bottero, Julie
    Hamers, Francoise
    Bergeron, Christine
    Haguenoer, Ken
    Launoy, Guy
    Luhmann, Niklas
    BMC WOMENS HEALTH, 2021, 21 (01)
  • [44] Uptake of cervical screening and acceptability of HPV self-sampling in Irish Traveller women
    O'Flynn, A.
    Fitzpatrick, P.
    Jalal, R.
    Frazer, K.
    Joye, R.
    Collins, M. B.
    Kavanagh, L.
    Mccarthy, T.
    Mcenery, M.
    Fox, P.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [45] Mapping evidence on the acceptability of human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review
    Dzobo, Mathias
    Dzinamarira, Tafadzwa
    Maluleke, Kuhlula
    Jaya, Ziningi Nobuhle
    Kgarosi, Kabelo
    Mashamba-Thompson, Tivani Phosa
    BMJ OPEN, 2023, 13 (04):
  • [46] Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study
    Zehbe, Ingeborg
    Moeller, Helle
    Severini, Alberto
    Weaver, Bruce
    Escott, Nicholas
    Bell, Crystal
    Crawford, Sandra
    Bannon, Diane
    Paavola, Natalie
    BMJ OPEN, 2011, 1 (01):
  • [47] Barriers to Acceptance of Self-sampling for Human Papillomavirus across Ethnolinguistic Groups of Women
    Howard, Michelle
    Lytwyn, Alice
    Lohfeld, Lynne
    Redwood-Campbell, Lynda
    Fowler, Nancy
    Karwalajtys, Tina
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2009, 100 (05): : 365 - 369
  • [48] Exploring the acceptability of human papillomavirus self-sampling among Muslim immigrant women
    Lofters, Aisha K.
    Vahabi, Mandana
    Fardad, Mitra
    Raza, Afrah
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 323 - 329
  • [49] Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study
    Aitken, Clare A.
    Inturrisi, Federica
    Kaljouw, Sylvia
    Nieboer, Daan
    Siebers, Albert G.
    Melchers, Willem J. G.
    van den Brule, Adriaan J. C.
    Molijn, Anco
    Hinrichs, John W. J.
    Niesters, Hubert G. M.
    van Kemenade, Folkert J.
    Berkhof, Johannes
    de Kok, Inge M. C. M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (02) : 183 - 192
  • [50] Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV
    Murphy, Jeanne
    Mark, Hayley
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2016, 20 (04) : e63 - e63